Novo Nordisk Probes Data Breach After Cyberattack

• Non-public data, including personal data, was copied externally without authorization during the breach
• The company has temporarily taken certain internal IT systems offline and is working to restore them in a controlled manner
• Core business operations remain functional and unimpacted by the security incident

Summary

Novo Nordisk Cybersecurity Incident

Danish pharmaceutical company Novo Nordisk announced on June 11 that it has identified a security breach involving unauthorized access to a limited number of internal IT systems. The company has confirmed that certain non-public data, including personal information, was copied externally without authorization.

Company Response:

• Launched investigation with external cybersecurity experts
• Contacted relevant authorities
• Temporarily taken certain internal IT systems offline
• Working to restore affected systems in a controlled manner
• Notifying impacted parties as appropriate

Operational Impact:

Novo Nordisk emphasized that core business operations remain unaffected and continue running normally despite the security incident.

Market Context:

The breach comes at a critical time for Novo Nordisk, a major player in the diabetes and obesity treatment markets. While the company has not disclosed the extent of the compromised data or potential financial impact, cybersecurity incidents at pharmaceutical companies raise concerns about intellectual property theft, regulatory compliance, and patient data protection.

The incident adds to growing cybersecurity challenges facing the pharmaceutical sector, where companies handle sensitive clinical trial data, proprietary research, and patient information. Investors will likely monitor for any updates regarding the breach's scope, potential regulatory penalties, and whether any critical business data or trade secrets were compromised.

No specific financial figures or timeline for full system restoration were provided in the announcement. The investigation remains ongoing.